Bevacizumab and vomiting 
Bevacizumab and vomiting Patient Reports February 10, 2012
Bevacizumab Side Effects Report #5253983-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Male patient, 76 years of age, weighting 172.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dehydration, vomiting. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5713406-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2008. Female patient, weighting 220.0 lb, was diagnosed with tonsil cancer, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: device related infection, oesophagitis, vomiting. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, RADIATION, DILAUDID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5765289-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypertension, hypothyroidism, nausea . Bevacizumab dosage: 15 MG/KG (690 MG) Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5782995-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 19, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , refusal of treatment by patient, treatment noncompliance. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5852586-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , refusal of treatment by patient. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6021215-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2008. Female patient, weighting 106.7 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, blood glucose increased, dizziness , nausea , pancreatic insufficiency. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5750324-0
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 21, 2008. Male patient, 69 years of age, weighting 135.8 lb, was diagnosed with rectal cancer, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastric antral vascular ectasia, gastric haemorrhage, gastroduodenal ulcer, haematemesis, nausea , unevaluable event. Bevacizumab dosage: 345 MG ONCE IV. During the same period patient was treated with NAPROXEN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5934853-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2008. Female patient, weighting 151.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, vomiting. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, RAMIPRIL, LEVOTHYROXINE, FUROSEMID, DIGITOXIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6092356-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2009. Male patient, weighting 201.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, disease progression, nausea . Bevacizumab dosage: 15MG/KG, 1370 MG EVERY 3 WEEKS IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5649791-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, pyrexia, vomiting. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, CAPECITABINE, GEMCITABINE, DICLOFENAC, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5991132-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 27, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, small intestinal obstruction, vomiting. Bevacizumab dosage: 442 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ACETAMINOPHEN, TRAMADOL, MEDROXYPROGESTERONE, PREMARIN, AMITRIPTYLINE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5027164-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2006. Male patient, 39 years of age, weighting 242.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, dysphagia, vomiting. Bevacizumab dosage: 5 MG/KG, DAYS 1 + 15, INTRAVENOUS. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5386875-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 05, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypomagnesaemia, hypophosphataemia, vomiting. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL TRANSDERMAL SYSTEM, MAALOX FAST BLOCKER, TYLENOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5391553-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: candidiasis, dehydration, diarrhoea, hypomagnesaemia, hypophosphataemia, vomiting. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL, MAALOX FAST BLOCKER, TYLENOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6042375-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2009. Male patient, weighting 186.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, febrile neutropenia, vomiting. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6062898-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2009. Male patient, weighting 186.0 lb, was diagnosed with oesophageal carcinoma, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysphagia, febrile neutropenia, vomiting. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, DOXYCYCLINE, ROXICET. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5728613-5
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 02, 2008. Male patient, 34 years of age, weighting 208.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cough, eructation, gastrointestinal necrosis, nausea
, oesophageal ulcer, retching. Bevacizumab dosage: 1035MG (15MG/KG) EVERY 21 TO 28 DAYS IV. Patient recovered.Bevacizumab Side Effects Report #6039223-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 08, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient died on 04/08/2007.Bevacizumab Side Effects Report #6075890-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 05, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5296017-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, weighting 133.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, constipation
, nausea . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5326312-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, disease progression, epistaxis, haemorrhage, mouth haemorrhage, unevaluable event, vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, CETUXIMAB, COUMADIN. Patient died.Bevacizumab Side Effects Report #5351069-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2007. Female patient, weighting 133.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, constipation
, nausea . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5554917-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 03, 2007. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE, JODID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5575032-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 12, 2007. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE, JODID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5612964-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 21, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, CARBOPLATIN, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE. Patient was hospitalized. Patient died on 01/07/2008.Bevacizumab Side Effects Report #5669964-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 05, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, pulmonary embolism , vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, CARBOPLATIN, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE. Patient was hospitalized. Patient died on 01/07/2008.Bevacizumab Side Effects Report #5701286-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, SEVREDOL. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #5724194-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 18, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, CARBOPLATIN, NOVALGIN, OMEPRAZOLE, FENTANYL CITRATE, LERCANIDIPINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5911237-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 22, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with ERLOTINIB, CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE, JODID. Patient was hospitalized. Patient died on 01/07/2008.Bevacizumab Side Effects Report #5922774-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 02, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-small cell lung cancer, pulmonary embolism
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with ERLOTINIB, CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL CITRATE, LERCANIDIPINE, JODID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5969552-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 17, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: headache
, hyperreflexia, myoclonic epilepsy, vomiting. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ERLOTINIB, PARACETAMOL, FENISTIL, PANTOZOL, CITALOPRAM HYDROBROMIDE, MORPHINE, HALOPERIDOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5977890-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 25, 2008. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #5983675-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 25, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: vomiting. Bevacizumab dosage: unknown. During the same period patient was treated with CHLORPHENIRAMINE MALEATE, MENTHOL, ACETAMINOPHEN. Patient was hospitalized. Patient died.
Bevacizumab Side Effects Report #6006449-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 02, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: headache
, hyperreflexia, myoclonic epilepsy, vomiting. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ERLOTINIB, ACETAMINOPHEN, FENISTIL, PANTOZOL, CITALOPRAM, MORPHINE, HALOPERIDOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6038013-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Male patient, weighting 193.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, dehydration, nausea , obstruction. Bevacizumab dosage: 10 MG/KG - IV Q2WEEKS 1 TREATMENT. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMBIVANT, LIPITOR, ZEMBETA, ZYRTEC, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6049470-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE, LANOXIN, METOPROLOL TARTRATE, MAG OXIDE, PREDNISONE, ALPRAZOLAM, GLUCOSAMINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #6053888-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 216.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, diarrhoea, dysuria, hypophagia, nausea
, neutropenia, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6055821-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 16, 2009. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, MORPHINE, ONDANSETRON. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #6072691-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 02, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased, thrombosis, vomiting. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6081055-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 02, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: headache
, hyperreflexia, myoclonic epilepsy, pyelonephritis, vomiting. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ERLOTINIB, ACETAMINOPHEN, FENISTIL, PANTOZOL, CITALOPRAM HYDROBROMIDE, MORPHINE, HALOPERIDOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4993515-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Female patient, weighting 169.1 lb, was diagnosed with neuroendocrine tumour, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, aortic thrombosis, back pain , blood pressure increased, chest pain , dyspnoea, vomiting. Bevacizumab dosage: 375 MG QS Q 2 WEEKS IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5127395-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 13, 2006. Male patient, 56 years of age, weighting 176.4 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: feeding tube complication, nausea
. Bevacizumab dosage: 812 MG WEEKS 1,3. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DULCOLAX, DECADRON, PRILOSEC, COMPAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5143840-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Male patient, 56 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration, dehydration, hiccups, nausea
, pneumonia . Bevacizumab dosage: 812MG WKS 1,3,5 DELAYED. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DULCOLAX, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5151045-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Male patient, 56 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea
. Bevacizumab dosage: 812MG WKS 1,3,5 DELAYED. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DUCLOLAX, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5725795-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 09, 2008. Female patient, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, feeding tube complication, infection
, nausea , oesophagitis, stomatitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, RADIATION. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5215812-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 02, 2007. Male patient, 38 years of age, was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, flatulence, gastrointestinal disorder, metastases to liver, metastases to lymph nodes, metastases to spleen, nausea . Bevacizumab dosage: 10 MG/KG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5156251-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea
, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 100 MG EVERY 3 WEEKS. During the same period patient was treated with ATENOLOL, VITAMIN CAP, XANAX, PREVACID, DOXAZOSIN MESYLATE, OTERACIL POTASSIUM, GIMERACIL, TEGAFUR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5179363-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea
, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 100 MG EVERY 3 WEEKS. During the same period patient was treated with ATENOLOL, VITAMIN CAP, XANAX, PREVACID, DOXAZOSIN MESYLATE, OTERACIL POTASSIUM, GIMERACIL, TEGAFUR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5324283-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 04, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5328627-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5498601-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, febrile neutropenia, muscle spasms, nausea
, small intestinal obstruction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5593106-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Male patient, weighting 176.4 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, anaemia, gastrointestinal haemorrhage, vomiting. Bevacizumab dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN D. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5827378-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 22, 2008. Male patient, weighting 334.9 lb, was diagnosed with malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, small intestinal obstruction, vomiting. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with LORTAB, REGLAN, ALTACE, ZOFRAN, FERROUS SULPHATE, BENTYL, SUPPLEMENTS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5004212-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with insulinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, chills, dehydration, vomiting. Bevacizumab dosage: 570 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PROTONIX, SANDOSTATIN, LORAZEPAM, GRANISETRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5021746-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with insulinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, chills, dehydration, diarrhoea, fatigue, vomiting. Bevacizumab dosage: 570 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, PROTONIX, SANDOSTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4699481-8
Bevacizumab side effect was reported by a Physician from on June 23, 2005. Female patient, 52 years of age, weighting 262.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, confusional state, dyspnoea, lung infiltration, productive cough, pyrexia, sputum discoloured, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4705470-7
Bevacizumab side effect was reported by a Physician from on June 30, 2005. Female patient, 52 years of age, weighting 202.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, confusional state, dyspnoea, productive cough, pyrexia, respiratory failure, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient died on 06/29/2005.
Bevacizumab Side Effects Report #4726142-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 25, 2005. Female patient, 52 years of age, weighting 202.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, lung infiltration, productive cough, pyrexia, respiratory failure, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient died on 06/29/2005.
Bevacizumab Side Effects Report #4724439-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 22, 2005. Female patient, 51 years of age, weighting 197.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, enteritis, nausea
. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, ALBUTEROL, CELEXA, COMPAZINE, GLYBURIDE, IBUPROFEN, LANCETS, LANTUS. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5668725-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2008. Female patient, 67 years of age, weighting 180.8 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, chest pain
, dehydration, nausea . Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5290488-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, fall
, hyponatraemia, nausea . Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5297826-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, disease progression, fall
, hyponatraemia, nausea , pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5173441-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2006. Female patient, weighting 152.8 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: grand mal convulsion, hypertension, hyponatraemia, nausea
, postictal paralysis. Bevacizumab dosage: 698MG QOW IV. During the same period patient was treated with IRINOTECAN, CARBATROL, PHENOBARBITAL, BONE CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5523581-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 15, 2007. Female patient, weighting 186.3 lb, was diagnosed with glioblastoma multiforme, fatigue, headache
, insomnia, dyspepsia, hypothyroidism, depression , deep vein thrombosis , prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood chloride increased, nervous system disorder, unresponsive to stimuli, vomiting. Bevacizumab dosage: 745 MG, Q2W. During the same period patient was treated with PROVIGIL, CODEINE SUL, AMBIEN, PROTONIX, LEVOTHYROXINE, NORTRIPTYLINE, LOVENOX, KEPPRA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4746442-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2005. Male patient, 24 years of age, weighting 158.7 lb, was diagnosed with gastrooesophageal cancer, metastasis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection
, blood culture positive, chest x-ray abnormal, neutropenia, pharyngolaryngeal pain, pyrexia, vomiting. Bevacizumab dosage: 15MG/KG IV DL EVERY 21 D. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, LEXAPRO, ZITHROMAX, CARAFATE, LORTAB ELAXER. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5595324-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 03, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, c-reactive protein increased, pyrexia, vomiting. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4799681-2
Bevacizumab side effect was reported by a Health Professional from ITALY on Sept 21, 2005. Female patient, 63 years of age, weighting 101.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium decreased, diarrhoea, nausea
, pyrexia. Bevacizumab dosage: 345 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, IRINOTECAN, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5300552-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2007. Male patient, weighting 142.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, oedema peripheral, pleural effusion, vomiting. Bevacizumab dosage: 330 MG, QOW. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, FOSAMAX, ZOCOR, ENALAPRIL MALEATE, AMARYL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5354593-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 05, 2007. Male patient, weighting 142.0 lb, was diagnosed with colorectal cancer metastatic, osteoporosis
, blood cholesterol, blood pressure , diabetes mellitus and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, oedema peripheral, pleural effusion, vomiting. Bevacizumab dosage: 330 MG, QOW. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, FOSAMAX, ZOCOR, ENALAPRIL MALEATE, AMARYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5431730-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 16, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood creatinine increased, blood urea increased, diarrhoea, musculoskeletal chest pain, nausea
, weight decreased. Bevacizumab dosage: 570 MG, Q3W. During the same period patient was treated with CAPECITABINE, IRINOTECAN, KETOPROFEN, LYTOS, TRAMADOL. Patient died on 08/09/2007.Bevacizumab Side Effects Report #5535651-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 23, 2007. Female patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastritis, nausea
. Bevacizumab dosage: 510 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN C. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5845809-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 31, 2008. Female patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastritis, nausea
. Bevacizumab dosage: 4000 MG, D1-14/Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, LOPERAMIDE, MICARDIS, TEMAZEPAM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6121797-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 03, 2009. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pericarditis, vomiting. Bevacizumab dosage: 510 MG, UNK. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5721937-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea , renal failure. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, HYDROCHLOROTHIAZIDE, LISINOPRIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5534770-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 21, 2007. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal impairment, vomiting. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, ISOVORIN, IRINOTECAN, OXYCONTIN, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5635044-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 08, 2008. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal impairment, vomiting. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, ISOVORIN, IRINOTECAN, OXYCONTIN, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5746946-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 12, 2008. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal impairment, vomiting. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, ISOVORIN, IRINOTECAN, OXYCONTIN, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5827260-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 15, 2008. Male patient, weighting 143.3 lb, was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea
, stomatitis. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, CANDESARTAN CILEXETIL, INDAPAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4917058-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Feb 16, 2006. Male patient, 50 years of age, weighting 178.6 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, nausea
. Bevacizumab dosage: 5MG/KG. During the same period patient was treated with OXALIPLATIN, CAPECITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5814027-6
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on June 19, 2008. Female patient, weighting 88.18 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea
, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, CALCIUM LEVOFOLINATE, DECADRON, NOVAMIN, DOMPERIDON, ACARBOSE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5922238-4
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Oct 02, 2008. Female patient, weighting 88.18 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea
, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, DECADRON, NOVAMIN, DOMPERIDON, ACARBOSE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4909411-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 10, 2006. Female patient, 56 years of age, weighting 166.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, malaise, neutropenia, oral intake reduced, pyrexia, vomiting. Bevacizumab dosage: 5MG/KG IV. During the same period patient was treated with OXALIPLATIN, ERLOTINIB, FLUOROURACIL, LEVOXYL, HYDROCHLOROTHIAZIDE, TOPROL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5319454-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 23, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, epistaxis, haematemesis, headache , oesophageal ulcer, photophobia, vomiting. Bevacizumab dosage: 575 MG, Q3W. During the same period patient was treated with CAPECITABINE, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5471948-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 14, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea
, oral intake reduced. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, FAMOTIDINE, FERROUS SULPHATE, ALUMINUM HYDROXIDE GEL, ALGINIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5491112-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2007. Female patient, weighting 135.6 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood potassium decreased, diarrhoea, vomiting. Bevacizumab dosage: 326 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, RABEPRAZOLE, ZOFRAN, PROCHLORPERAZINE, ALUMINUM HYDROXIDE GEL, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5497597-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 11, 2007. Female patient, weighting 303.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, pyrexia, vomiting. Bevacizumab dosage: 312.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL, NEUPOGEN, MODULON, IRON SUPPLEMENT. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5503210-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 16, 2007. Female patient, weighting 135.6 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, hypokalaemia, vomiting. Bevacizumab dosage: 326 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, RABEPRAZOLE, ZOFRAN, PROCHLORPERAZINE, ALUMINUM HYDROXIDE GEL, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5557768-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 30, 2007. Female patient, weighting 303.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, febrile neutropenia, oesophageal candidiasis, vomiting. Bevacizumab dosage: 660 MG, Q3W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, NEUPOGEN, MODULON, IRON SUPPLEMENT, PANTOPRAZOLE, DOMPERIDONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5809746-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 01, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, gallbladder obstruction, vomiting. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5916980-9
Bevacizumab side effect was reported by a Physician from FRANCE on Sept 29, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: metastases to meninges, vomiting. Bevacizumab dosage: 600 MG, Q2W. During the same period patient was treated with TAXOL. Patient died on 05/20/2008.
Bevacizumab Side Effects Report #5443251-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Female patient, 65 years of age, weighting 192.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , bronchitis , laryngitis, mental status changes, sepsis , sinusitis , vomiting. Bevacizumab dosage: 15MG/KG Q3WKS (IV). During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5446684-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2007. Female patient, 53 years of age, weighting 147.7 lb, was diagnosed with breast cancer
, depression , hypothyroidism and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, dehydration, diarrhoea, diverticulum intestinal, headache , hepatic cyst, hypovolaemia, vomiting, white blood cell count increased. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CYCLOPHOSPHAMIDE, DOXORUBICIN, ASACOL, ENTOCORT EC, EFFEXOR, TRAZODONE, SYNTHROID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5884894-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 15, 2008. Female patient, 46 years of age, weighting 154.1 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure, dyspnoea, fatigue, malaise, nausea , productive cough. Bevacizumab dosage: 15MG/KG IV Q 3 WEEKS. During the same period patient was treated with CAPECITABINE, ATIVAN, EFFEXOR. Patient was hospitalized. Patient died on 09/04/2008.Bevacizumab Side Effects Report #5132911-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 19, 2006. Female patient, weighting 142.4 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain lower, lower gastrointestinal haemorrhage, nausea . Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS 042. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5406983-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2007. Male patient, weighting 116.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia, renal impairment, vomiting. Bevacizumab dosage: 10 MG/KG Q3WEEKS IV. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5551523-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 29, 2007. Female patient, weighting 167.6 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, headache , pyrexia, vomiting. Bevacizumab dosage: 760 MG, UNK. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5853292-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea , pyrexia. Bevacizumab dosage: 1350 MG, UNK. During the same period patient was treated with EPIRUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5344168-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Male patient, weighting 177.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, dyspnoea, gastrointestinal disorder, hiccups, large intestine perforation, nausea , pneumoperitoneum. Bevacizumab dosage: 402 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5393810-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 20, 2007. Male patient, weighting 201.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: feeding disorder, nausea
, oral intake reduced, weight decreased. Bevacizumab dosage: 5MG/KG Q 3 WEEKS IV. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5398923-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Male patient, weighting 159.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: faeces discoloured, haematemesis, nausea
, oesophagitis ulcerative, regurgitation. Bevacizumab dosage: 369 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5398924-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Male patient, weighting 159.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: faeces discoloured, haematemesis, nausea
, regurgitation. Bevacizumab dosage: 369 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5409690-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Male patient, weighting 159.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, nausea
, oesophageal haemorrhage, oesophagitis ulcerative, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: unknown. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5441740-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2007. Male patient, weighting 159.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: faeces discoloured, gastrointestinal haemorrhage, nausea
, oesophagitis ulcerative, platelet count abnormal, white blood cell count abnormal. Bevacizumab dosage: 369 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5546738-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2007. Female patient, weighting 148.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure increased, headache
, vomiting. Bevacizumab dosage: 664 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5672383-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 11, 2008. Male patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, cardio-respiratory arrest, convulsion, hiccups, peritonitis, respiratory failure, sepsis , vomiting. Bevacizumab dosage: 5 MG/KG, Q2W. Patient was hospitalized and became disabled. Patient died on 10/20/2007.Bevacizumab Side Effects Report #5673950-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2008. Female patient, weighting 112.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, colonoscopy abnormal, diarrhoea haemorrhagic, intestinal ischaemia, vomiting. Bevacizumab dosage: 508 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, GABAPENTIN, HYDROCLORATHIAZIDE, RAMPRIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5801400-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 03, 2008. Female patient, weighting 124.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, colitis ischaemic, defaecation urgency, nausea , rectal haemorrhage. Bevacizumab dosage: 848 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.